Because IGF-1 is a key anabolic factor for muscle protein synthesis, reduced circulating or tissue IGF-1 in severe or protracted COVID-19 may contribute to sarcopenia and muscle loss [105,106]. This evidence concerns the gene IGF1 and sarcopenia.